Remote Therapeutic Monitoring Market Size, Share, and Industry Analysis, By Product Type (Device {Remote Patient Monitor, Patient Isolation Transport Unit, Nurse Call System, and Others}, and Software), By Application (Musculoskeletal, Respiratory Conditions, and Others), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI114803

Remote Therapeutic Monitoring Market Overview

The global remote therapeutic monitoring market is expected to grow with a significant CAGR over the years due to the growing popularity of patient monitoring software, the shift toward value-based care, and cost reduction due to reduced hospitalizations, among other factors. These factors have led to the increasing adoption of remote therapeutic monitoring by hospitals and other qualified healthcare professionals for public health monitoring and policy development. The remote therapeutic monitoring (RTM) program focuses on using digital technologies to monitor non-physiological data from patients with musculoskeletal and pulmonary conditions or as part of cognitive behavioral therapy.

RTM is used for adhering to medication regimens, treatment protocols, rehabilitation exercise routines, and cognitive behavioral therapy practices, among others. The platforms actively monitor musculoskeletal or respiratory status, medication response, and other key metrics. Additionally, RTM allows increased revenue generation with minimal additional workload on clinical staff, improved patient communication, more personalized care plans, and faster responses to patient recovery issues.

Furthermore, to capitalize on the market potential due to these benefits, various key operational entities are streamlining their focus on strategic collaboration to improve their product offering with technological advancement and contribute to the market growth.

For instance, in July 2025, HealthArc, a remote monitoring platform, partnered with PatchRx, a smart medication adherence technology manufacturer. The collaboration aimed to deliver a novel remote therapeutic monitoring program tailored to pain management practices. The company's integrated its solutions to provide a comprehensive, connected offering for patients to improve medication adherence.

Remote Therapeutic Monitoring Market Driver

Increasing Funding Activities that Support New Product Development to Drive Market Growth

The use of remote therapeutics monitoring devices and software is on the rise to provide value-based care and reduced hospitalizations, among other benefits. Advancing algorithms in artificial intelligence (AI) amplify the potential of remote therapeutic monitoring platforms by analyzing vast data sets and providing real-time insights. Additionally, AI and machine learning (ML) facilitate the use of therapeutic monitoring by precise data analysis, early detection of health deterioration, personalizing care, and automating tasks.

Furthermore, key players are taking strategic initiatives to focus on patient monitoring and participating in funding activities to sustain research and development for technological advancement and new product launches.

For instance, in February 2023, LainaHealth, formerly known as IncludeHealth, a provider of AI-powered musculoskeletal technology solutions, raised USD 11.0 million in a series funding. The funding was led by CincyTech, Tamarind Hill, and other investors further to expand MSK-OS, the Company's remote care platform. IncludeHealth's platform is utilized by health systems, physical therapy networks, orthopedic practices, and the government for remote therapeutic monitoring and value-based care. Such developments are expected to propel the growth of the global remote therapeutic monitoring market.

Prevalence of Musculoskeletal Disorders for Key Regions in 2021 (in millions)

In October 2024, NIH published an article titled ‘From Pain to Progress: Comprehensive Analysis of Musculoskeletal Disorders Worldwide’ that reported the prevalence of musculoskeletal diseases across key countries.

Remote Therapeutic Monitoring Market Restraint

High Prices Associated with the Deployment of Remote Therapeutic Monitoring May Hamper Its Adoption in Market

The remote therapeutic monitoring requires a highly interoperable IT infrastructure, expensive medical devices, complex software, with other integrated health systems. This shoots up the deployment prices of such remote therapeutic devices and software. Such high prices associated with deploying these product offerings may hamper the product adoption and restrict the market growth.

For instance, in April 2025, Octal IT Solution published a blog reporting that although the cost of remote therapeutic software may vary based on various factors, the development of an RTM software solution can range from USD 50,000 to USD 500,000 or more.

Remote Therapeutic Monitoring Market Opportunity

Multilingual expansion in Remote Therapeutics Monitoring Software and Reimbursement Initiatives to Aid a Wider Range of Patients and Provide Market Growth Avenues.

The global remote therapeutic monitoring market is poised for growth due to increasing demand for precise therapeutic monitoring devices worldwide. Integrating numerous languages from different parts of the world into this software provides a significant growth opportunity for the market. RTM mainly focuses on non-physiological data reported by patients themselves. The expansion of multilingual local languages facilitates the utilization and helps adopt this software. Owing to these factors, many established players focus on integrating various languages in remote therapeutic monitoring software.

For instance, in January 2025, Adhere+, a telehealth company, released its latest platform update, v1.20, featuring a foreign language engine, beginning with comprehensive Spanish-language support. The new foreign language engine enabled translation of remote therapeutic monitoring (RTM) protocols, patient notifications, and app interfaces. This update empowered practices to provide personalized, culturally responsive care to a broader range of patients, while improving communication, adherence, and clinical outcomes.

Furthermore, various reimbursement initiatives by the Centers for Medicare & Medicaid Services (CMS) also support adopting patient therapeutic monitoring software and devices and contribute to the market growth. The reimbursement is allocated with the help of certain CPT codes for RTM, such as 98975 for setup and education, 98977 for monitoring, and 98980/98981 for interactive communication, allowing billing for different aspects of remote monitoring.

RTM can be billed simultaneously with certain care management programs, such as Chronic Care Management (CCM), Advanced Primary Care Management, Transitional Care Management, Behavioral Health Integration, and Chronic Pain Management. Such factors to propel the growth of the market in the forecasted years.

Key Insights

The report covers the following key insights:

Technological Advancement in the Market
Reimbursement Scenario, By Key Countries/ Regions
Regulatory Scenario, By Key Countries/ Regions
Key Industry Development- (Mergers, Acquisitions, Partnerships, etc.)
Key Startups in the Market

Segmentation

By Product Type	By Application	By End User	By Region
Device Remote Patient Monitor Patient Isolation Transport Unit Nurse Call System Others Software	Musculoskeletal Respiratory Conditions Others	Hospitals & ASCs Specialty Clinics Others	North America (U.S. and Canada) Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Analysis by Application

By application, the market is divided into musculoskeletal, respiratory conditions, and others.

The musculoskeletal segment is expected to dominate the global remote therapeutic monitoring market. The segment's high market share is due to the increasing use of RTM for musculoskeletal disease. Athletes and professional sportspersons often incorporate these technologies while recovering from their injuries. Among the remote therapeutic codes established by CMA, four can be utilized for patients who have musculoskeletal disorders. Such factors reinforce the lead of the segment in the market.

Additionally, technological advancement and a better user interface with this therapeutic monitoring software are further expected to support the adoption of remote therapeutics in the forthcoming years.

For instance, in March 2024, EverEx received the iF Design Award for MORA, a leading musculoskeletal rehabilitation software. The software won among 11,000 entries from 72 countries due to its exceptional functionality, user interface, and experience. MORA product lines provided EverEx's proprietary AI pose estimation model-powered musculoskeletal assessment and personalized rehabilitation treatment with remote therapeutic monitoring—such developments to bolster the segmental growth.

Analysis by Product Type

The global remote therapeutic market is segmented into device and software, based on product type. The device is further classified into remote patient monitor, patient isolation transport unit, nurse call system, etc. The FDA approves these devices for monitoring the therapeutic progression of patients. Furthermore, various strategic product launches and collaborations among numerous operation entities and approvals by regulatory bodies are expected to drive the market growth in the forecasted years.

For instance, in May 2020, AR Tech, a division of A&R Tarpaulins Inc., an aerospace and medical equipment manufacturer, received emergency approval for using its Patient Isolation Transportation Unit (PITU) from the Food and Drug Administration. PITU is designed to temporarily isolate and transport patients with confirmed or suspected COVID-19 infection. Such factors propel the growth of the segment in the market.

Analysis by End User

By end user, the market is divided into hospitals & ASCs, specialty clinics, and others.

Hospitals and ASCs are expected to hold a substantial market share in the global market. These hospitals and ambulatory surgical centres are medical practitioners' first point of contact for patient care and collecting data. Also, a large hospital patient population necessitates adopting remote therapeutic software to manage and track patient history. These factors drive the growth of the segment in the forecasted period. Furthermore, key operational entities are enhancing this software to cater to the needs of hospitals and ASCs through strategic collaborations.

For instance, in July 2024, Smith+Nephew, a medical technology company, collaborated with Healthcare Outcomes Performance Company (HOPCo) for exclusive digital and advanced analytics. The collaboration focused on enhancing solutions for ASC, physicians, and patients through HOPCo's digital health and analytics platforms, myrecovery and Vitals. These platforms enhance the clinical experience through patient engagement tools such as RTM, remote care management, etc. Such developments are bolstering the segmental growth.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization to gain extensive market insights.

North America is expected to account for the largest global remote therapeutic monitoring market share. The growth is attributed to vigorous spending on healthcare services and robust IT infrastructure, digitalization of health records, and growing adoption of patient monitoring software and services in the region. These factors facilitate the adoption of remote therapeutic monitoring software.

Additionally, established players are expanding their market presence by strategic launches to ensure the availability of this software in key markets.

For instance, in September 2022, Force Therapeutics announced the availability of its Remote Therapeutic Monitoring (RTM) solution. The company's provider-prescribed digital care management platform has been validated to provide compliant documentation for the new RTM Current Procedural Terminology (CPT) codes finalized by the Centers for Medicare and Medicaid Services. Such developments are expected to favor the market growth in the region.

Europe is the second-largest market based on the demand for remote therapeutic monitoring. The region's substantial market share is due rising geriatric population, the rising prevalence of chronic diseases, the need for accessible healthcare, and advancements in technology. These remote monitoring software and devices can improve medication adherence in elderly patients and promote independence. They also assist in providing insights into patient progression and effectiveness. Such factors heighten the demand for healthcare and analytics.

Moreover, key players participate in strategic collaborations to enhance their presence and offer regional monitoring solutions through strategic distribution collaborations.

For instance, in May 2025, Medtronic expanded its Acute Care & Monitoring portfolio in Europe with a new distribution agreement for the Corsano multi-parameter wearable. These factors drive the regional growth.

Asia Pacific is also expected to grow with the most significant CAGR in the global remote therapeutic monitoring market forecast year. The demand for remote therapeutic monitoring devices is rising in the region due to growing expenditure on health. Additionally, various key players are involved in strategic activities such as collaborations and partnerships to meet the growing demands in the region.

For instance, in December 2024, Adherium, an Australian company, partnered with Tenovi to advance remote therapeutic monitoring for patients with chronic respiratory diseases. The partnership aimed to improve outcomes and reduce the total cost of care for patients with chronic illnesses who fail to take medication. Such development reinforces the growth of the market in the region.

Key Players Covered

The global remote therapeutic monitoring market is fragmented, with a large number of group and standalone providers.

The report includes the profiles of the following key players:

Force Therapeutics (U.S.)
Circadian Health, Inc. (U.S.)
MiCare Path (U.S.)
Tenovi (U.S.)
HealthViewX. (U.S.)
Smart Pillbox (U.S.)
MD Revolution Inc. (Coachcare) (U.S.)
Zimmer Biomet (U.S.)
Simbo AI. (U.S.)

Key Industry Developments

In March 2025, Circadian Health partnered with Tenovi, a leading provider of remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) devices. The partnership aimed to further scale the virtual-first specialty care model to support the growing demand for real-time remote patient care. This collaboration enhances Circadian's hospital-at-home model, empowering payers and employers to expand chronic disease management, drive earlier interventions, and improve patient outcomes.
In September 2024, Carematrix launched a blinded blood pressure monitor and scale designed to monitor patients' vitals in masked clinical trials remotely. The device enabled remote data monitoring devices to take blood pressure and weight readings without viewing patients' data.
In July 2024, MD Revolution, a remote care management company, collaborated with PatchRx. With the collaboration, the company's RevUp and RevCare solutions will integrate with PatchRx's medication adherence platform, PatchRx Connect. The collaboration enabled clinicians to include medication adherence as a part of their patients' remote care management plan, enabling a broader suite of remote care options for their patients.
In August 2023, Monidor, a Finnish health technology company, cooperated with B. Braun to revolutionize remote monitoring of IV therapy. This partnership represents considerable progress in the supervision of infusion therapy.
In August 2022, WebPT, the leading rehab therapy platform, launched the Keet Remote Therapeutic Monitoring (RTM) Dashboard and enhanced integrations with WebPT and Insight EMRs. The platform enabled users with real-time integration with the Keet platform, including its new RTM capabilities.